These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 8657367

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL, Lin HJ, Lau JN, Flok AS, Wu PC, Chung HT, Wong LK, Leung MP, Yeung CY.
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [Abstract] [Full Text] [Related]

  • 26. [Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].
    Glück T, Weber P, Wiedmann KH.
    Dtsch Med Wochenschr; 1994 Oct 14; 119(41):1388-92. PubMed ID: 7924948
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparison of 2 treatment strategies with prednisone and interferon in chronic hepatitis B].
    Gómez Camacho F, Poyato González A, Vignote Alguacil ML, de La Mata García M, González Fernández RA, López Rubio F, Marchal Molina T, Miño Fugarolas G.
    Rev Esp Enferm Dig; 1996 Mar 14; 88(3):185-90. PubMed ID: 8645511
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC, Brice E, van Rensburg C, Kannemeyer J, Hift RJ, Kirsch RE.
    S Afr Med J; 1992 Nov 14; 82(5):317-20. PubMed ID: 1448711
    [Abstract] [Full Text] [Related]

  • 31. Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.
    Gonzalez-Mateos F, Garcia-Monzon C, Garcia-Buey L, Garcia-Sanchez A, Pajares JM, Moreno-Otero R.
    Hepatogastroenterology; 1995 Nov 14; 42(6):893-9. PubMed ID: 8847042
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Müller R, Baumgarten R, Markus R, Schulz M, Wittenberg H, Hintsche-Kilger B, Fengler JD, von Wussow P, Meisel H, Klein H.
    Dtsch Med Wochenschr; 1990 Mar 16; 115(11):403-7. PubMed ID: 2178900
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Longitudinal follow-up study of 64 children chronically infected with hepatitis B virus, treated and not treated with interferon].
    Vetencourt R, Vetencourt M, De Armas J.
    G E N; 1995 Mar 16; 49(3):227-33. PubMed ID: 8598262
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Pathogenesis and alpha-2 interferon treatment of chronic hepatitis B].
    Pirotte J.
    Rev Med Liege; 1996 Aug 16; 51(8):514-21. PubMed ID: 8927872
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.